Naveen Pemmaraju: How to Improve AML Outcomes With Lower-Intensity Triplets
Naveen Pemmaraju/ youtube.com

Naveen Pemmaraju: How to Improve AML Outcomes With Lower-Intensity Triplets

Naveen Pemmaraju, Director of Leukemia-Cancer Network, Executive Director of Cancer Medicine, Director of BPDCN at the Department of Leukemia, and Professor at the Department of Leukemia at MD Anderson Cancer Center, shared a post on X:

“Excellent review article led by Dr Wei Ying Jen and Dr DiNardo on Optimizing lower intensity triplet tx in AML-a practical guide.”

Title: Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide

Authors: Wei-Ying Jen, Curtis A. Lachowiez, Jennifer Marvin-Peek, Jessica K. Altman, Musa Yilmaz, Jacqueline S. Garcia, Yasmin Abaza, Nicholas J. Short, Joshua F. Zeidner, Naval G. Daver, Andrew H. Wei, Ghayas C. Issa, Courtney D. DiNardo

Read The Full Article

Naveen Pemmaraju

Other articles about AML on OncoDaily.